Gilead Sciences
Biotechnology
GILD
$ 63 1.4
Share price
$ 79 bn
Market Cap
$ 102 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Gilead Sciences aims to reduce Scope 1 + 2 by 46% by 2030 from a base year 2019
1.5°C
Secondary Climate Goal
Gilead Sciences aims to reduce Scope 3 by 15% by 2030 from a base year 2019
1.5°C
GHG emissions and Carbon intensity
Gilead Sciences reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 84 Kt (+12/+16% y-o-y). Carbon intensity also was up at 3.4 t (+0.2/+6.2% y-o-y).
Gilead Sciences's Scope 3 emissions surged to 38 Kt (
The company is committed to reducing Scope 1 + 2 by 46% by 2030 from a base year 2019, which translates into the estimated reduction of -4.5 Kt per annum over the period of FY2021 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.
Copyright © 2022 Exerica. All rights reserved.